Senseonics Holdings, Inc. (NYSE:SENS) Receives Consensus Recommendation of “Buy” from Analysts

Senseonics Holdings, Inc. (NYSE:SENS) has been given an average recommendation of “Buy” by the six analysts that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation, three have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $26.40.

SENS has been the subject of several recent analyst reports. Barclays initiated coverage on Senseonics in a research note on Wednesday, August 27th. They set an “overweight” rating and a $30.00 target price for the company. TD Cowen assumed coverage on Senseonics in a research note on Tuesday, July 15th. They set a “buy” rating and a $25.00 target price for the company. Lake Street Capital raised Senseonics to a “strong-buy” rating in a research note on Thursday, July 17th. Stifel Nicolaus assumed coverage on Senseonics in a research note on Tuesday. They issued a “hold” rating and a $9.00 price objective for the company. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $28.00 price objective (up from $22.00) on shares of Senseonics in a research note on Tuesday, July 8th.

Senseonics Price Performance

SENS stock opened at $6.93 on Thursday. The business has a fifty day moving average of $8.97 and a two-hundred day moving average of $10.37. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. The stock has a market cap of $282.29 million, a price-to-earnings ratio of -53.31 and a beta of 0.83. Senseonics has a 52-week low of $5.00 and a 52-week high of $28.00.

Institutional Investors Weigh In On Senseonics

A number of institutional investors have recently modified their holdings of SENS. First Light Asset Management LLC grew its stake in shares of Senseonics by 666.7% in the second quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company’s stock valued at $17,011,000 after buying an additional 31,050,619 shares in the last quarter. Hood River Capital Management LLC purchased a new position in Senseonics in the second quarter valued at $3,775,000. Sio Capital Management LLC purchased a new position in Senseonics in the second quarter valued at $2,312,000. Geode Capital Management LLC boosted its holdings in Senseonics by 26.6% in the second quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock valued at $4,147,000 after purchasing an additional 1,828,302 shares during the period. Finally, Sei Investments Co. purchased a new position in Senseonics in the second quarter valued at $761,000. 12.36% of the stock is owned by institutional investors and hedge funds.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.